[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650844":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":35,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":10,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":56,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Markusovszky University Teaching Hospital os County Vas","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Primary study cohort",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Oliver L Stari, MD","CONTACT","011-36-94-311542","stari.oliver@gmail.com",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Markusovszky University Teaching Hospital","RECRUITING","Szombathely","Vas County","9700","Hungary","HU",{"type":27,"coordinates":28},"Point",[29,30],16.62155,47.23088,{"lat":30,"lon":29},[33],{"name":34,"role":14,"phone":15,"phoneExt":10,"email":16},"Oliver Laszlo Stari, MD",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Oliver Laszlo Stari","Principal Investigator","100650844","diagnostic-prediction-model-for-de-novo-metastatic-breast-cancer-100650844",false,"NCT07752238","Diagnostic Prediction Model for De Novo Metastatic Breast Cancer","Development of a Diagnostic Prediction Model for de Novo Metastatic Breast Cancer Using Routinely Available Baseline Parameters","Inclusion Criteria:\n\n* Female sex, aged 18 years or older.\n* Newly diagnosed invasive breast cancer.\n* Case reviewed by the Multidisciplinary Tumour Board at the study site during the inclusion period (between October 1, 2018, and July 31, 2025).\n* No history of prior or synchronous invasive malignancies, except for synchronous bilateral breast cancer.\n* Intent for primary treatment and clinical management at the study site.\n* Availability of longitudinal clinical records throughout the 12-month follow-up period or until death.\n\nExclusion Criteria:\n\n-Absence of baseline systemic staging.","FEMALE","18 Years",{"count":49,"type":50},925,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to create a tool to estimate the risk of macroscopic distant tumor spread in women with newly diagnosed breast cancer. The main question it aims to answer is:\n\n• Can a model, which combines routine medical information collected at diagnosis, accurately predict if a patient has metastasis large enough to be found during systemic imaging? Researchers will review the past medical records of participants who were treated at a university hospital. Because this study looks at past data, participants will not be asked to do any new tasks, take new tests, or change their medical care.",[54,55],"Breast Cancer","Metastatic Invasive Breast Cancer",[57,58,59],"de novo metastasis","breast cancer","predictive modelling","2026-08-10",{"date":62,"type":63},"2026-08-12","ACTUAL",{"date":60,"type":63},{"date":66,"type":50},"2027-02-28",{"name":5,"class":6},1]